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Background/aim: The knowledge of factors influencing functional outcomes after aneurysmal subarachnoid hemorrhage (ASH) has
significantly increased in recent decades, still not enough. We aimed to identify the predictors of full functional recovery (FFR) in
endovascularly treated patients with ASH.
Materials and methods: A retrospective review was performed of adult patients who underwent endovascular treatment for ASH in
a 5-year period. The association was evaluated of variables with FFR, defined as a modified Rankin Scale score of 0 or 1 at a 3-month
follow-up.
Results: This study included 204 patients with a percentage of FFR of 62.7%. On univariate analysis, the following variables were
associated with FFR: younger age, male sex, no history of hypertension, posterior circulation aneurysm, better modified-Fisher grade
(mFG), better Hunt-Hess grade, better Glasgow Coma score, lower platelet-to-lymphocyte ratio (PLR), lower neutrophil-to-lymphocyte
ratio (NLR), and higher platelet-to-neutrophil ratio (PNR). On multivariate analysis, younger age (OR = 0.95, 95% Cl = 0.92–0.98, p =
0.003), better mFG (OR = 0.66, 95% Cl = 0.48–0.97, p = 0.03), lower PLR (OR = 0.993, 95% Cl = 0.990–0.997, p = 0.001), lower NLR
(OR = 0.89, 95% Cl = 0.83–0.95, p = 0.01) and higher PNR (OR = 1.08, 95% Cl = 1.01–1.10, p = 0.01) showed the strongest association
with FFR.
Conclusion: With the administration of endovascular treatment, most of the patients with ASH can return to a normal productive life.
Younger age, better mFG, lower PLR and NLR, as well as higher PNR, increase the likelihood of FFR.
Key words: Subarachnoid hemorrhage, cerebral aneurysm, outcome, prediction

1. Introduction
Thanks to the advances in supportive neurocritical care and
refinements either in surgical or endovascular treatment
(EVT), the prognosis of patients with a ruptured cerebral
aneurysm has remarkably improved over time [1–4]. To
achieve a much better outcome, many studies have been
performed to test the influence of various factors on the
functional, as well as cognitive outcomes after aneurysm
rupture, mainly regarding consequential disability [5–7].
However, no consensus has emerged among researchers
over the validity of factors tested, perhaps because of the
differences in research design, as well as the ethnicity of
the study population. Besides, new variables have been
added to the checklist in recent years, including novel
inflammatory markers [8]. Given that the therapeutic goal
should be the best outcome in patients with aneurysmal
subarachnoid hemorrhage [9], in this study, we aimed
to identify the predictors of full functional recovery in a

contemporary series of endovascularly treated patients
with a ruptured cerebral aneurysm.
2. Materials and methods
2.1. Study population
After approval of the local Ethical Committee, a
retrospective chart review was conducted using the
electronic medical record identifying adult patients
who underwent an EVT for cerebral aneurysm, at our
angiography unit during the period between January 2015
to May 2020. Among them, patients with an unruptured
aneurysm, fusiform aneurysm or unsuccessful treatment
were excluded from this study (Figure).
2.2. Study protocol
Demographic characteristics and previous medical history
(i.e., history of hypertension, diabetes, coronary artery
disease, and cerebrovascular disease) of the patients
were identified. In addition, the location and size of the
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Endovascular aneurysm repair:
January 2015 - May 2020
n = 350
Excluded:
Incidental aneurysm (n = 144)
Fusiform aneurysm (n = 1)
Failed pro cedure (n = 1)

Patients enrolled
n = 204

Figure. Flow chart showing the selection of the study population.

aneurysms were inspected. Location of the aneurysms
was mainly assessed in two groups: anterior or posterior
circulation aneurysms. Aneurysmal size was measured
in maximum diameter, either on preoperative CT
angiography or intraoperative 3D rotational angiography.
The size of fusiform aneurysms was not included in the
evaluation. The amount of subarachnoid blood was
graded using the modified Fisher scale, using the first
available noncontrast enhanced CT scan. The Hunt &
Hess scale grade and the Glasgow coma scale score of the
patients were the other clinical scores identified (please
see Table 1 for the definition of all these three scales used
in the study) [10]. The period elapsed from aneurysm
rupture to EVT was calculated, as well. The endovascular
technique used for the embolizations was investigated.
Procedural complications, such as aneurysm perforation
and thromboembolism, were identified. Thromboembolic
events were assessed in two subgroups: angiographically
evident thromboembolism and microemboli. The latter
included the patients without angiographic evidence of
thromboembolism during EVT but with neurological
deficit recognized upon recovery of the general anesthesia.
Intraoperative administrations of intraarterial tirofiban
hydrochloride (HCl) and tissue plasminogen activator
(tPA) were identified, too. Novel inflammatory markers,
such as platelet-to-lymphocyte ratio (PLR), platelet-toneutrophil ratio (PNR), and neutrophil-to-lymphocyte
ratio (NLR), were the last parameters investigated. All
3 ratios were calculated by proportioning the absolute
counts of each type of cell at admission.
Based on the information provided in the medical
records, the functional outcomes of the patients were
evaluated using the modified Rankin scale (mRS)
score. As the primary outcome measure, we defined full
functional recovery at three months as an mRS score of
0–1 (0 = no symptoms at all, 1 = no significant disability
despite symptoms and able to carry out all usual duties and

activities), representing full functional recovery (please
see Table 2 for the definition of mRS) [11].
2.3. Statistical analysis
Statistical Package for Social Sciences for Windows, v.
21.0 (SPSS, Chicago, IL, USA) was used for statistical
analysis. For continuous variables, data summaries were
expressed as mean ± standard deviation, with a median
value in brackets. For categorical variables, frequencies
(percentage) were reported. To analyze whether the
variables assessed in the study could cause a difference
in the outcome, the Mann–Whitney U test was used for
continuous variables or the chi-square test for categorical
variables. Univariate and multivariate logistic regression
analyses were used to evaluate the associations between
the variables specified in the study protocol and the mRS
score of 0 to 1 (best/not) as a binary outcome. A p-value of
less than 0.05 was considered statistically significant.
3. Results
In this study, 204 patients were assessed. The mean age of
the patients was 55.4 ± 14.2 years. Of the 204 patients, 119
(58.3%) were women. In 91 (44.6%) patients, there was
at least one chronic comorbid disease. The frequencies
of hypertension, diabetes, coronary artery disease and
cerebrovascular disease were 53.9%, 7.4%, 9.3%, and 1.9%,
respectively. The most common location of the aneurysms
was anterior communicating artery (43.6%). The mean
aneurysmal size was 6.0 ± 3.0 mm. The means of two
subarachnoid hemorrhage grading scales of modified
Fisher and Hunt & Hess were 2.1 ± 1.1 and 1.5 ± 0.9,
respectively. The mean Glasgow coma score was 13.8 ±
2.3. The mean interval between the aneurysm rupture and
the treatment was 6.1 ± 7.5 days. Primary coiling was the
most common technique used for embolization (67.2%),
which was followed by balloon-assisted coiling (13.2%),
stent-assisted coiling (10.2%), flow diverter implant
(7.8%), and others (1.6%), respectively. The frequency
of procedural complications was 17.6%: aneurysm
perforation in six patients (2.9%), angiographically evident
thromboembolism in 26 patients (12.7%), and microemboli
in four patients (1.9%). It was detected that tirofiban HCl
was intraoperatively administered in 30 (14.7%) patients
because of the following purposes: mainly to dissolve
blood clots or to prevent clotting due to a stent which had
to be implanted without preoperative antiplatelet loading.
In 12 (5.9%) patients, tissue plasminogen activator was
intraoperatively administered alone or in combination
with tirofiban HCL to dissolve blood clots. The means of
PLR, PNR, and NLR were 216.1 ± 13.1, 25.8 ± 11.7, and
9.8 ± 6.4, respectively. Full functional recovery was seen
in 128 (62.7%) patients. Results of the parametric and
nonparametric tests are summarized in Table 3.
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Table 1. Definitions of the scales used in this study.
The modified Fisher grade
Grade

CT manifestations

1

No hemorrhage

2

Extensive bleeding but no blood clots, the thickness of blood products <1 mm

3

The thickness of the blood products >1 mm

4

Intracerebral hematoma or intraventricular hemorrhage

The Hunt-Hess grade
Grade

Early prognosis

1

No symptoms, or only mild headache and neck stiffness

2

A heavy, stiff neck, in addition to oculomotor nerve palsy, without any symptoms of the nervous system

3

Mild disturbance of consciousness, restlessness, and mild symptoms of brain

4

Semicoma, hemiplegia, decerebrate rigidity, and autonomic nervous disorder at early stage

5

Deep coma, decerebrate rigidity, endangered state

The Glasgow coma scale
Response
Eye opening
response

Verbal
response

Motor
response

Scale

Score

Eyes open spontaneously

4

Eyes open to verbal command, speech, or shout

3

Eyes open to pain (not applied to face)

2

No eye opening

1

Oriented

5

Confused conversation, but able to answer questions

4

Inappropriate responses, words discernible

3

Incomprehensible sounds or speech

2

No verbal responses

1

Obeys commands for movement

6

Purposeful movement to painful stimulus

5

Withdraws from pain

4

Abnormal (spastic) flexion, decorticate posture

3

Extensor (rigid) response, decerebrate posture

2

No motor response

1

Results of the univariate analyses are summarized in
Table 4. The following variables were associated with better
chances of achieving full functional recovery: younger age,
male sex, no history of hypertension, posterior circulation
aneurysm, better modified Fisher and Hunt & Hess
grades, better Glasgow coma score, lower PLR, lower NLR,
and higher PNR. According to multivariate analysis, the
following five variables were the most strongly associated
with full functional recovery: younger age, better modified
Fisher grade, lower PLR, lower NLR, and higher PNR
(Table 5).
4. Discussion
The prognosis of patients with aneurysmal subarachnoid
hemorrhage is a highly studied research topic. However,
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achieving full functional recovery is an aspect that has
been rarely examined. There are only few studies focusing
on the prediction of full functional outcomes, which has
remained under-researched [9,12]. Instead, the poor
outcome has been the target of most studies. This is perhaps
because of the old prejudice; aneurysmal subarachnoid
hemorrhage is a crippling disease anyway. Hence, a less
than moderate disability has not been regarded as a failure.
Given that the survival rate has significantly increased,
and the prognosis of such patients has improved over time
thanks to the advances in supportive neurocritical care
and refinements in surgical and endovascular treatment,
a paradigm shift is needed, whereby the primary outcome
measure after aneurysmal bleeding should be fully
functional recovery rather than functional independent
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Table 2. The modified Rankin scale.
Score

Description

0

No symptoms

1

No significant disability. Able to carry out all usual activities, despite some symptoms

2

Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities

3

Moderate disability. Requires some help, but able to walk unassisted

4

Moderate severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted

5

Severe disability. Requires constant nursing care and attention, bedridden, incontinent

6

Dead
Table 3. Comparison of variables according to functional recovery at 3 months.
Variable

mRS score of 0–1
(n = 128)

mRS score of 2–6
(n = 76)

p value

Mean age ± SD (median) (years)

52.1 ± 13.4 (54)

60.9 ± 13.9 (60)

<0.001

Female sex

67 (52.3%)

52 (68.4%)

0.03

Hypertension history

60 (46.8%)

50 (65.7%)

0.01

Anterior circulation aneurysm

111 (86.7%)

73 (96%)

0.05

Mean aneurysmal size ± SD (median) (mm)

6.0 ± 2.9 (5.6)

6.0 ± 3.3 (5)

0.33

Mean mFisher grade ± SD (median)

1.9 ± 1.0 (2)

2.6 ± 1.0 (2.5)

<0.001

Mean Hunt & Hess grade ± SD (median)

1.3 ± 0.7 (1)

1.9 ± 1.1 (1)

0.001

Mean Glasgow Coma score ± SD (median)

14.3 ± 1.6 (15)

13.1 ± 3 (14)

<0.001

Mean interval ± SD (median) (days)

6.4 ± 7.4 (4)

5.7 ± 7.6 (3)

0.22

Coil embolization

87 (67.9%)

50 (65.7%)

0.86

Procedural complication

18 (14.0%)

18 (23.6%)

0.12

Tirofiban HCl therapy†

14 (10.9%)

16 (21.0%)

0.07

tPA therapy

5 (3.9%)

7 (9.2%)

0.21

Mean PLR ± SD (median)

194.8 ± 109.8 (173.2)

251.8 ± 110.3 (240.7)

<0.001

Mean PNR ± SD (median)

28.4 ± 13.0 (25.7)

21.5 ± 7.5 (19.2)

<0.001

Mean NLR ± SD (median)
8.1 ± 5.9 (7.0)
12.6 ± 6.3 (11.5)
<0.001
mFisher = modified Fisher, mRS = modified Rankin scale, NLR = neutrophil-to-lymphocyte ratio, PLR = platelet-tolymphocyte ratio, PNR = platelet-to-neutrophil ratio, SD = standard deviation, tPA = tissue plasminogen activator.
†Indicates the number of patients who were administered tirofiban HCl during the procedure.
Boldface type indicates statistical significance.

status [13]. Having achieved such an outcome in almost
two-thirds of the patients in this study, the suggestion has
shown to be realistic.
The modified Rankin scale, as well as the Glasgow
outcome scale, has mainly been used to measure
functional outcomes in patients who underwent aneurysm
repair at either short-term or long-term follow-up. To our
knowledge, this is the first study focusing on full functional
outcomes at short-term follow-up. Therefore, it is hard to
compare our results directly with other researches. In our
study, the frequency of the patients who recovered full
function was almost the same (62.7% vs. 63.3%) compared

with findings from Pegoli et al.’s study [9]; however,
in which the follow-up duration was one year. Unlike
them, we found that younger age, male sex, no history of
hypertension and posterior circulation aneurysm were
associated with full functional recovery. In their study,
coil embolization was associated with full functional
(excellent, in their words) outcome. However, we only saw
a trend towards a higher rate of such an outcome with coil
embolization. In another study published by Giede-Jebbe
et al. [14], the findings showed that lower age, as well as
no history of hypertension, was associated with a favorable
outcome. Although ruptured posterior circulation
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Table 4. Univariate analyses demonstrating the association of
variables with full functional recovery (mRS score of 0–1).

Table 5. Multivariate analyses demonstrating independent
associations with full functional recovery (mRS score of 0–1)*

Variable

OR (95% CI)

p value

Variable

OR (95% CI)

p value

Age (years)

0.95 (0.93–0.97)

<0.001

Age (years)

0.95 (0.92–0.98)

0.003

Female sex

0.50 (0.28–0.91)

0.02

mFisher grade

0.66 (0.48–0.97)

0.03

Hypertension history

0.45 (0.25–0.82)

0.009

PLR

0.993 (0.990–0.997)

0.001

Anterior circulation aneurysm

0.26 (0.07–0.94)

0.04

PNR

1.08 (1.01–1.10)

0.01

mFisher grade

0.54 (0.40–0.70)

<0.001

NLR

0.89 (0.83–0.95)

0.01

Hunt & Hess grade

0.56 (0.41–0.78)

<0.001

Glasgow coma score

1.26 (1.09–1.46)

0.001

PLR

0.99 (0.993–0.998) 0.001

PNR

1.06 (1.03–1.10)

<0.001

NLR

0.88 (0.83–0.93)

<0.001

Cl = confidence interval, mFisher = modified Fisher, mRS =
modified Rankin scale, NLR = neutrophil-to-lymphocyte ratio,
OR = odds ratio, PLR = platelet-to-lymphocyte ratio, PNR =
platelet-to-neutrophil ratio.

aneurysms were shown to have a poor prognosis and a
higher rate of death or severe disability due to the deeper
position and more complex morphology compared with
anterior circulation aneurysms [10], we found an opposite
result, which was surprising to us. This may be due to
the dominance of the patients with anterior circulation
aneurysm in the study group. Aneurysmal size was not
a factor related to the outcome in our study, more likely
because the sizes of aneurysms in both outcome groups
were closer to each other.
Like in the previous studies, the impact of admission
status on the prognosis has been confirmed [15–17]. A
better modified Fisher grade, as well as a better Hunt &
Hess grade, was associated with full functional recovery on
the univariate analysis. However, no association of the same
strength between Hunt & Hess grade and full functional
recovery was detected on the multivariate analysis.
According to us, this is because the Hunt & Hess Scale
is relatively less objective than the modified Fisher scale.
The differences between grade 1 and 2, as well as between
grade 2 and 3, are particularly equivocal on this scale. For
instance, the severity of headache and neck stiffness makes
the difference between grade 1 and 2 [18]. Since objective
grading with this scale can be difficult from time to time,
some patients who should be given a higher grade may be
given a lower grade [19]. If this was the case in our study
population, it might have overshadowed the strength of
the association of Hunt & Hess grade with the outcome of
the multivariate analysis. Besides, with the advancement
in treatment technology as aforementioned above, some of
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Cl = confidence interval, mFisher = modified Fisher, mRS =
modified Rankin scale, NLR = neutrophil-to-lymphocyte ratio,
OR = odds ratio, PLR = platelet-to-lymphocyte ratio, PNR =
platelet-to-neutrophil ratio.
*The multivariate regression model includes all variables entered
into the univariate analyses, but only those with statistical
significance are expressed.

the patients with a Hunt & Hess grade of over 3 have been
shown to be able to have a good prognosis, as happened in
our cases [10,20]. The latter may have also influenced the
result to come out like this.
The rate of overall procedural complications, including
the aneurysm perforations and thromboembolic events,
was 17.6% in our study, which was consistent with the
results of previous studies [21–24]. For instance, Dinç
et al. [23] reported a complication rate of 15.6% in their
series, including 481 patients presenting with a ruptured
or an unruptured cerebral aneurysm. The complication
rate was lower in our cases with full functional recovery
compared with the patients with poor prognosis (14%
vs. 23.6%). Moreover, in this study, it was detected that
the intraoperative administration of tirofiban HCl was
more frequent in patients with a 3-month mRS score
of 2 or greater. A similar result was seen regarding tPA
administration, despite insignificant statistical differences
in both circumstances. Contrary to expectations, these
results revealed that the occurrence of procedural
complications is not an obstacle to a full functional
recovery. However, it should not be overlooked that the
main underlying factor behind this success is the proper
management of the complications.
Cerebrovascular event-associated immunosuppression
is increasingly recognized as a factor worsening functional
outcomes after a stroke or intracerebral hemorrhage
[8,14,25–27]. For instance, Tao et al. [25] reported that PLR
and NLR were associated with an unfavorable outcome
after subarachnoid hemorrhage. Giede-Jeppe et al. [14]
showed a similar relationship regarding higher NLR. Our
findings were consistent with the results of these previous
studies. We found that lower PLR and NLR, as well as
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higher PNR, were strongly associated with full functional
recovery. Excessive neuroinflammation triggered by
hemorrhage-related endothelial injury explains the
elevation in white blood cell counts, including neutrophil
count [28]. However, the question of why lymphocyte and
neutrophil counts are oppositely affected by subarachnoid
hemorrhage remains unclear. We could not obtain a
satisfactory answer to this question from the literature
[14]. In our opinion, this is an interesting phenomenon to
study.
This study has several limitations. Some of the variables
previously investigated in the literature were not available
in the medical records of our cases, such as the history of
smoking. Thus, such an analysis could not be performed
including them. In addition, we could not evaluate
the effects of hemorrhagic vasospasm on the outcome
because, at our hospital, surveillance for vasospasm has
mainly been conducted with monitoring of clinical signs
but without using imaging techniques unless a sudden
clinical deterioration emerges. We could not also assess

the influence of secondary hydrocephalus on the outcome
because we did not have firm standardized criteria for
evaluation. Finally, it would be better to report long-term
outcomes in such a study. However, since the long-term
outcomes of some of the patients included in the study were
not yet available, we only reported short-term outcomes
by this study. We plan to publish the long-term outcomes
of a larger series of patients in the upcoming period.
Returning to normal productive life is possible in most
of the endovascularly treated patients with a ruptured
cerebral aneurysm. Particularly, patients at a younger age
or patients with less severe bleeding are more likely to
recover full function. PLR and PNR, as well as NLR, can be
used as independent predictors of full functional recovery
after aneurysm rupture.
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